Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia

• Lisa Christiansson ,

  * E-mail: lisa.christiansson@igp.uu.se

  Affiliation Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden

  ⨯
• Stina Söderlund,

  Affiliation Department of Medical Sciences, Uppsala University and Department of Hematology, University Hospital, Uppsala, Sweden

  ⨯
• Emma Svensson,

  Affiliation Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden

  ⨯
• Satu Mustjoki,

  Affiliation Hematology Research Unit Helsinki, Department of Medicine, Division of Hematology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Mats Bengtsson,

  Affiliations Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden, Section of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, Uppsala, Sweden

  ⨯
• Bengt Simonsson,

  Affiliation Department of Medical Sciences, Uppsala University and Department of Hematology, University Hospital, Uppsala, Sweden

  ⨯
• Ulla Olsson-Strömberg,

  Affiliation Department of Medical Sciences, Uppsala University and Department of Hematology, University Hospital, Uppsala, Sweden

  ⨯
• Angelica S. I. Loskog

  Affiliation Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden

  ⨯